ATE27914T1 - Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung. - Google Patents

Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.

Info

Publication number
ATE27914T1
ATE27914T1 AT84400997T AT84400997T ATE27914T1 AT E27914 T1 ATE27914 T1 AT E27914T1 AT 84400997 T AT84400997 T AT 84400997T AT 84400997 T AT84400997 T AT 84400997T AT E27914 T1 ATE27914 T1 AT E27914T1
Authority
AT
Austria
Prior art keywords
acetyl
beta
alpha
allergic
manufacture
Prior art date
Application number
AT84400997T
Other languages
English (en)
Inventor
Henri Chibret
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Application granted granted Critical
Publication of ATE27914T1 publication Critical patent/ATE27914T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
AT84400997T 1983-05-24 1984-05-16 Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung. ATE27914T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8308495A FR2546407B1 (fr) 1983-05-24 1983-05-24 Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique
EP84400997A EP0131477B1 (de) 1983-05-24 1984-05-16 Verwendung von N-acetyl(alpha, beta) aspartylglutaminsäure zur Herstellung eines Arzneimittels mit anti-allergischer Wirkung zur lokalen Verabreichung

Publications (1)

Publication Number Publication Date
ATE27914T1 true ATE27914T1 (de) 1987-07-15

Family

ID=9289095

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84400997T ATE27914T1 (de) 1983-05-24 1984-05-16 Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.

Country Status (7)

Country Link
US (1) US5000936A (de)
EP (1) EP0131477B1 (de)
JP (1) JPS59227826A (de)
AT (1) ATE27914T1 (de)
DE (1) DE3464333D1 (de)
FR (1) FR2546407B1 (de)
GR (1) GR82030B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655543B1 (fr) * 1989-12-11 1992-02-21 Therapeutique Applic Sa Nouvelle preparation pharmaceutique anti-allergique a action prolongee, a base d'acide n-acetyl aspartyl glutamique.
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
US5498410A (en) * 1991-04-22 1996-03-12 Gleich; Gerald J. Method for the treatment of eosinophil-associated conditions with anionic polymers
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5859017A (en) * 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US6159958A (en) * 1997-08-14 2000-12-12 The United States Of America As Represented By The Secretary Of The Army Treatment or prophylaxis of retinal pathology and spinal cord injury
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US20050070468A1 (en) * 2001-11-21 2005-03-31 Sucampo Ag Use of fk506 and analogues for treating allergic diseases
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
GB0213437D0 (en) * 2002-06-12 2002-07-24 Univ Cranfield Temporary tattoos: A novel vehicle for skin testing
US20040127395A1 (en) * 2002-09-06 2004-07-01 Desai Pragnya J. Use of histamine H4 receptor modulators for the treatment of allergy and asthma
US7632818B2 (en) * 2003-03-20 2009-12-15 Gottlieb Marise S Method for treating conditions associated with the Metabolic Syndrome (Syndrome X)
US6949262B1 (en) * 2003-05-27 2005-09-27 Lousal Enterprises, Inc. Skin and mucosal treatment formulation
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1141632A (en) * 1965-02-27 1969-01-29 Serono Ist Farm Improvements in or relating to glutamic acid derivatives
FR2257270A1 (en) * 1974-01-11 1975-08-08 Ferlux CNS-Active N-acyl-asparagyl-glutamic acids and salts - prepd by reacting N-acyl aspartic acid with anhydride, then reaction with glutamic acid salt
CH665645A5 (fr) * 1981-07-09 1988-05-31 Michel Flork Derives de dipeptides et leur procede de preparation.
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤

Also Published As

Publication number Publication date
EP0131477A1 (de) 1985-01-16
US5000936A (en) 1991-03-19
EP0131477B1 (de) 1987-06-24
GR82030B (de) 1984-12-12
FR2546407B1 (fr) 1986-04-18
DE3464333D1 (en) 1987-07-30
JPH0222733B2 (de) 1990-05-21
JPS59227826A (ja) 1984-12-21
FR2546407A1 (fr) 1984-11-30

Similar Documents

Publication Publication Date Title
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
ATE27914T1 (de) Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
DE3677842D1 (de) Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
MX3375A (es) Procedimiento de preparacion de nuevas benzamidas y sus sales, producto obtenido y composicion farmaceutica que lo incluye.
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ES552948A0 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos.
FR2541576B1 (fr) Medicament contenant de la muzolimine et son procede de preparation
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
ZA83856B (en) Thiazaspirane derivatives,processes for their preparation,and medicaments
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
DE3675378D1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
NO870834L (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
DE3686534D1 (de) Verwendung eines retinoids zur herstellung eines zytostatischen arzneimittels.
AT375938B (de) Verfahren zur herstellung von 9-amino-6,7-dihydro-4h-pyrido (1,2-a) pyrimidin-4-on-derivaten, deren physiologisch vertraeglichen salzen, hydraten und isomeren
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
ATE89563T1 (de) Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
PT67628A (de) Verfahren zur herstellung von fungiziden mitteln mit 2,4-dichlorphenyl-triazolyl-athanone-(-ole),und dessen physiologisch vertraglichen salze mit fungizide mittel
ATE146963T1 (de) Verwendung von tergurid zur herstellung eines arzneimittels zur behandlung geriatrischer beschwerden
DE3886034D1 (de) Verfahren zur Herstellung von 2,4-Dihydroxychinolin-Derivaten.
ATA134577A (de) Verfahren zur herstellung von 9,10- dihydroergosin und dessen physiologisch bertraeglichen saeureadditionssalzen
ES2076517T3 (es) Ergolinas disustituidas en posiciones 2,13, su preparacion y utilizacion en medicamentos.
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time